查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1810975

2025年新一代体外诊断（IVD）全球市场报告

Next-Generation In Vitro Diagnostics (IVD) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计下一代体外诊断 (IVD) 市场将在未来几年强劲成长，到 2029 年将达到 1,720.2 亿美元，年复合成长率（CAGR）为 9.9%。预测期内的成长归因于个人化医疗的进步、医疗保健支出的增加、研发活动的活性化、感染疾病病率的上升以及慢性疾病患者的激增。预测期内的主要趋势包括技术创新、人工智慧和机器学习在诊断中的应用、先进诊断技术的进步、个人化医疗以及新型生物标记的发现。

个人化医疗需求的不断增长预计将在未来几年推动下一代体外诊断 (IVD) 市场的成长。个人化医疗是一种根据个人基因图谱、环境和生活方式来客製化疾病预防和治疗方案的医疗保健方法。个人化医疗的成长得益于基因组数据的日益普及，这使得医疗保健提供者能够根据个人独特的基因组成开发标靶治疗，从而获得更有效的治疗方案。下一代体外诊断 (IVD) 透过提供准确的分子和遗传资讯来支持个人化医疗，为每位患者制定个人化的治疗和预防策略。例如，2024 年 2 月，美国医院和医疗保健组织个人化医疗联盟 (Personalized Medicine Coalition) 报告称，FDA 在 2023 年核准了16 种针对罕见疾病患者的新型个人化疗法，高于 2022 年的 6 种。因此，个人化医疗需求的不断增长正在推动下一代体外诊断 (IVD) 市场的扩张。

下一代体外诊断（IVD）市场的关键参与者正在建立策略伙伴关係关係，与技术提供者、研究机构和医疗保健组织合作，以加速创新，提高诊断准确性，并扩大个人、企业和政府获得先进检测解决方案的管道。策略伙伴关係关係使公司能够利用彼此的优势和资源，实现互利通用。例如，2024 年 10 月，英国生技公司 Yourgene Health 与哥伦比亚人类基因诊断公司 Genetix 合作，推出了哥伦比亚首个本地可用的非侵入性产前检测 (NIPT) 服务。这项倡议标誌着该地区产前检测的重大进步，为准父母提供了更快、更可靠、更具成本效益的先进基因筛检。该服务采用 Yourgene Health 的 IONA Nx NIPT 工作流程，这是一种获得 CE 标誌认证的综合体外诊断 (IVD) 解决方案。此工作流程灵活且扩充性，可适应各种样本量，使 Genetix 能够在整个哥伦比亚提供品质有保证的产前筛检服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球新一代体外诊断（IVD）：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球新一代体外诊断（IVD）市场：成长率分析
  • 全球下一代体外诊断 (IVD) 市场表现：规模与成长，2019-2024 年
  • 全球新一代体外诊断 (IVD) 市场预测：2024-2029 年及 2034 年规模与成长
  • 全球新一代体外诊断（IVD）：总目标市场（TAM）

第六章市场区隔

  • 全球新一代体外诊断 (IVD) 市场：按产品类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 装置
  • 软体
  • 全球下一代体外诊断 (IVD) 市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 核心实验室诊断
  • 就地检验
  • 分子诊断
  • 全球新一代体外诊断 (IVD) 市场：按应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 肿瘤学或癌症
  • 感染疾病
  • 糖尿病
  • 心臟病学
  • 其他用途
  • 全球下一代体外诊断 (IVD) 市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 学术研究机构
  • 其他最终用户
  • 全球新一代体外诊断 (IVD) 市场：按耗材 (类型)、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 条码标籤
  • 无线射频识别标籤
  • 检体袋和管
  • 标籤色带
  • 密封件和盖子
  • 全球新一代体外诊断 (IVD) 市场：按设备类型、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 条码扫描器
  • 射频识别读取器
  • 标籤印表机
  • 工作站和终端
  • 储运监控设备
  • 全球新一代体外诊断 (IVD) 市场：按软体类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 实验室资讯管理系统
  • 样本追踪软体模组
  • 云端基础的追踪软体
  • 条码和无线射频识别（RFID）整合平台
  • 检体追踪的行动应用程式

第七章 区域和国家分析

  • 全球新一代体外诊断 (IVD) 市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球下一代体外诊断 (IVD) 市场：按国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 下一代体外诊断（IVD）市场：竞争格局
  • 下一代体外诊断（IVD）市场：公司简介
    • F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Grifols SA
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Revvity Inc.
  • Exact Sciences Corporation
  • QIAGEN NV
  • DiaSorin SpA
  • Singular Genomics Systems Inc.
  • Guardant Health Inc.
  • Pacific Biosciences of California Inc.
  • Transasia Bio-Medicals Ltd.
  • Athena Dx
  • J Mitra and Co Pvt Ltd

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年新一代体外诊断 (IVD) 市场：提供新机会的国家
  • 2029年新一代体外诊断（IVD）市场：细分市场带来新机会
  • 2029年下一代体外诊断（IVD）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r37077

Next-generation in vitro diagnostics (IVD) refers to advanced diagnostic tools and technologies that examine biological samples-such as blood, saliva, or tissue-outside the body to identify diseases, conditions, or infections with enhanced accuracy, speed, and personalization. These technologies often incorporate innovations like genomics, artificial intelligence, digital health platforms, and high-throughput sequencing. The main goal of next-generation IVD is to facilitate earlier, more precise, and patient-tailored diagnosis and monitoring of diseases, including cancer, infectious diseases, and genetic disorders.

The primary product categories in next-generation in vitro diagnostics (IVD) include consumables, instruments, software, and others. Core laboratory diagnostics involve centralized testing services that process a wide variety of biological samples using automated, high-throughput instruments and assays. This encompasses types such as core laboratory diagnostics, point-of-care testing, and molecular diagnostics. These tools are applied across various fields, including oncology, infectious diseases, diabetes, cardiology, and other diagnostic areas, serving a diverse range of end users like hospitals and clinics, diagnostic laboratories, academic and research institutions, and other healthcare providers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The next-generation in vitro diagnostics (IVD) market research report is one of a series of new reports from The Business Research Company that provides next-generation in vitro diagnostics (IVD) market statistics, including next-generation in vitro diagnostics (IVD) industry global market size, regional shares, competitors with a next-generation in vitro diagnostics (IVD) market share, detailed next-generation in vitro diagnostics (IVD) market segments, market trends and opportunities, and any further data you may need to thrive in the next-generation in vitro diagnostics (IVD) industry. This next-generation in vitro diagnostics (IVD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The next-generation in vitro diagnostics (IVD) market size has grown rapidly in recent years. It will grow from $106.97 billion in 2024 to $117.97 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to the growing geriatric population, increased government funding, escalating investments in genomic research, expansion in clinical trials, and greater consumer health awareness.

The next-generation in vitro diagnostics (IVD) market size is expected to see strong growth in the next few years. It will grow to $172.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be credited to the expanding advancement of personalized medicine, rising healthcare expenditures, increasing research and development activities, growing incidence of infectious diseases, and a surge in chronic disease cases. Key trends during the forecast period include technological innovations, the incorporation of artificial intelligence and machine learning in diagnostics, progress in advanced diagnostic technologies, personalized medicine, and the discovery of novel biomarkers.

The rising demand for personalized medicine is expected to drive the growth of the next-generation in vitro diagnostics (IVD) market moving forward. Precision medicine is a healthcare approach that tailors disease prevention and treatment based on an individual's genetic profile, environment, and lifestyle. The growth of personalized medicine is fueled by the increasing availability of genomic data, enabling healthcare providers to develop targeted treatments based on a person's unique genetic makeup, resulting in more effective care. Next-generation in vitro diagnostics (IVD) supports personalized medicine by delivering precise molecular and genetic insights that facilitate customized treatment and prevention strategies for individual patients. For example, in February 2024, the Personalized Medicine Coalition, a US-based hospital and healthcare organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the growing demand for personalized medicine is driving the expansion of the next-generation in vitro diagnostics (IVD) market.

Key players in the next-generation in vitro diagnostics (IVD) market are adopting strategic partnerships by collaborating with technology providers, research institutions, and healthcare organizations to accelerate innovation, improve diagnostic accuracy, and broaden access to advanced testing solutions for individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve shared benefits and success. For instance, in October 2024, Yourgene Health, a UK-based biotechnology company, partnered with Genetix, a Colombia-based human genetic diagnosis company, to introduce Colombia's first local non-invasive prenatal testing (NIPT) service. This initiative marks a significant advancement in prenatal care within the region, providing expectant parents with faster, more reliable, and cost-effective access to advanced genetic screening. The service employs Yourgene Health's IONA Nx NIPT Workflow, a comprehensive, CE-marked in vitro diagnostic (IVD) solution. This workflow is highly flexible and scalable, accommodating varying sample volumes, and enables Genetix to offer a quality-assured prenatal screening service throughout Colombia.

In February 2023, SD Biosensor Inc., a South Korea-based in-vitro diagnostics company, along with SJL Partners LLC, a South Korea-based investment firm, acquired Meridian Bioscience Inc. for $1.53 billion. Through this acquisition, SD Biosensor aims to leverage Meridian's expertise in diagnostic products and raw materials used in immunological and molecular tests across various applications. Meridian Bioscience Inc. is a US-based diagnostic company specializing in in vitro diagnostic enzymes.

Major players in the next-generation in vitro diagnostics (IVD) market are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols SA, Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Revvity Inc., Exact Sciences Corporation, QIAGEN NV, DiaSorin SpA, Singular Genomics Systems Inc., Guardant Health Inc., Pacific Biosciences of California Inc., Transasia Bio-Medicals Ltd., Athena Dx, and J Mitra and Co Pvt Ltd.

North America was the largest region in the next-generation in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in next-generation in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation in vitro diagnostics (IVD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation in vitro diagnostics (IVD) market consists of revenues earned by entities providing services such as genomic testing services, molecular diagnostics services, and companion diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation in vitro diagnostics (IVD) market also includes sales of molecular diagnostics kits, proteomics-based diagnostic kits, and NGS sample preparation kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation In Vitro Diagnostics (IVD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The next-generation in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Consumables; Instruments; Software
  • 2) By Type: Core Laboratory Diagnostics; Point-Of-Care Testing; Molecular Diagnostics
  • 3) By Application: Oncology Or Cancer; Infectious Diseases; Diabetes; Cardiology ; Other Applications
  • 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Users
  • Subsgements:
  • 1) By Consumables: Barcode Labels; Radio Frequency Identification Tags; Specimen Bags and Tubes; Labeling Ribbons; Seals and Caps
  • 2) By Instruments: Barcode Scanners; Radio Frequency Identification Readers; Label Printers; Workstations and Terminals; Storage and Transport Monitoring Devices
  • 3) By Software: Laboratory Information Management Systems; Specimen Tracking Software Modules; Cloud-Based Tracking Software; Barcode and Radio Frequency Identification Integration Platforms; Mobile Applications for Specimen Tracking
  • Companies Mentioned: F Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson and Company; Quest Diagnostics Incorporated; Grifols SA; Agilent Technologies Inc.; Illumina Inc.; Sysmex Corporation; Bio-Rad Laboratories Inc.; Revvity Inc.; Exact Sciences Corporation; QIAGEN NV; DiaSorin SpA; Singular Genomics Systems Inc.; Guardant Health Inc.; Pacific Biosciences of California Inc.; Transasia Bio-Medicals Ltd.; Athena Dx; J Mitra and Co Pvt Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next-Generation In Vitro Diagnostics (IVD) Market Characteristics

3. Next-Generation In Vitro Diagnostics (IVD) Market Trends And Strategies

4. Next-Generation In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Next-Generation In Vitro Diagnostics (IVD) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Next-Generation In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Next-Generation In Vitro Diagnostics (IVD) Market Growth Rate Analysis
  • 5.4. Global Next-Generation In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Next-Generation In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Next-Generation In Vitro Diagnostics (IVD) Total Addressable Market (TAM)

6. Next-Generation In Vitro Diagnostics (IVD) Market Segmentation

  • 6.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Instruments
  • Software
  • 6.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Core Laboratory Diagnostics
  • Point-Of-Care Testing
  • Molecular Diagnostics
  • 6.3. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology Or Cancer
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Other Applications
  • 6.4. Global Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Academic And Research Institutions
  • Other End Users
  • 6.5. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Barcode Labels
  • Radio Frequency Identification Tags
  • Specimen Bags And Tubes
  • Labeling Ribbons
  • Seals And Caps
  • 6.6. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Barcode Scanners
  • Radio Frequency Identification Readers
  • Label Printers
  • Workstations And Terminals
  • Storage And Transport Monitoring Devices
  • 6.7. Global Next-Generation In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Information Management Systems
  • Specimen Tracking Software Modules
  • Cloud-Based Tracking Software
  • Barcode And Radio Frequency Identification Integration Platforms
  • Mobile Applications for Specimen Tracking

7. Next-Generation In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 7.1. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Next-Generation In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market

  • 8.1. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation In Vitro Diagnostics (IVD) Market

  • 9.1. China Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 9.2. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation In Vitro Diagnostics (IVD) Market

  • 10.1. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation In Vitro Diagnostics (IVD) Market

  • 11.1. Japan Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 11.2. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation In Vitro Diagnostics (IVD) Market

  • 12.1. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market

  • 13.1. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation In Vitro Diagnostics (IVD) Market

  • 14.1. South Korea Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 14.2. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market

  • 15.1. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 15.2. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation In Vitro Diagnostics (IVD) Market

  • 16.1. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation In Vitro Diagnostics (IVD) Market

  • 17.1. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation In Vitro Diagnostics (IVD) Market

  • 18.1. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation In Vitro Diagnostics (IVD) Market

  • 19.1. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation In Vitro Diagnostics (IVD) Market

  • 20.1. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market

  • 21.1. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 21.2. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation In Vitro Diagnostics (IVD) Market

  • 22.1. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation In Vitro Diagnostics (IVD) Market

  • 23.1. North America Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 23.2. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation In Vitro Diagnostics (IVD) Market

  • 24.1. USA Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 24.2. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation In Vitro Diagnostics (IVD) Market

  • 25.1. Canada Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 25.2. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation In Vitro Diagnostics (IVD) Market

  • 26.1. South America Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 26.2. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation In Vitro Diagnostics (IVD) Market

  • 27.1. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation In Vitro Diagnostics (IVD) Market

  • 28.1. Middle East Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 28.2. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation In Vitro Diagnostics (IVD) Market

  • 29.1. Africa Next-Generation In Vitro Diagnostics (IVD) Market Overview
  • 29.2. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Next-Generation In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 30.1. Next-Generation In Vitro Diagnostics (IVD) Market Competitive Landscape
  • 30.2. Next-Generation In Vitro Diagnostics (IVD) Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • 31.1. Grifols SA
  • 31.2. Agilent Technologies Inc.
  • 31.3. Illumina Inc.
  • 31.4. Sysmex Corporation
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Revvity Inc.
  • 31.7. Exact Sciences Corporation
  • 31.8. QIAGEN NV
  • 31.9. DiaSorin SpA
  • 31.10. Singular Genomics Systems Inc.
  • 31.11. Guardant Health Inc.
  • 31.12. Pacific Biosciences of California Inc.
  • 31.13. Transasia Bio-Medicals Ltd.
  • 31.14. Athena Dx
  • 31.15. J Mitra and Co Pvt Ltd

32. Global Next-Generation In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation In Vitro Diagnostics (IVD) Market

34. Recent Developments In The Next-Generation In Vitro Diagnostics (IVD) Market

35. Next-Generation In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 35.1 Next-Generation In Vitro Diagnostics (IVD) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Next-Generation In Vitro Diagnostics (IVD) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Next-Generation In Vitro Diagnostics (IVD) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer